FRNM · Freenome Inc. Common stock
View on chartInsiders & Stakes
| PERCEPTIVE ADVISORS LLC Director | ▲ Buy | Grant | 10,871,847 Shares held | 7/20/2026 | View profile |
| Perceptive Capital Solutions Holdings | ▼ Sell | Other | 2,352,500 Shares held | 7/20/2026 | View profile |
| Adam Leo Stone Chief Executive Officer | ▼ Sell | Other | 2,352,500 Shares held | 7/20/2026 | View profile |
| Michael Seth Altman Chief Business Officer | ▼ Sell | Other | 2,352,500 Shares held | 7/20/2026 | View profile |
| RA CAPITAL MANAGEMENT, L.P. Director | ▲ Buy | Grant | 1,245,068 Shares held | 7/20/2026 | View profile |
| Elliott Aaron Matthew Chief Executive Officer | ▼ Sell | Tax Withholding | 345,976 Shares held | 9/2/2026 | View profile |
| Harlan Waksal | ▼ Sell | Other | 30,000 Shares held | 7/20/2026 | View profile |
| Kenneth Song | ▼ Sell | Other | 30,000 Shares held | 7/20/2026 | View profile |
| Mark C. McKenna | ▼ Sell | Other | 30,000 Shares held | 7/20/2026 | View profile |
Transaction History
| Elliott Aaron Matthew | ▼ Sell | Tax Withholding | 71,920 | $1.1M | 9/2/2026 |
| Kenneth Song | ▼ Sell | Other | 30,000 | — | 7/20/2026 |
| Perceptive Capital Solutions Holdings | ▼ Sell | Other | 2,066,250 | — | 7/20/2026 |
| PERCEPTIVE ADVISORS LLC | ▲ Buy | Grant | 5,500,000 | $55.0M | 7/20/2026 |
| Mark C. McKenna | ▼ Sell | Other | 30,000 | — | 7/20/2026 |
| Adam Leo Stone | ▼ Sell | Other | 2,066,250 | — | 7/20/2026 |
| Michael Seth Altman | ▼ Sell | Other | 2,066,250 | — | 7/20/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 6,561,711 | — | 7/20/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 970,950 | — | 7/20/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 553,703 | — | 7/20/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 908,103 | — | 7/20/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 367,427 | — | 7/20/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 4,918,411 | $49.2M | 7/20/2026 |
| RA CAPITAL MANAGEMENT, L.P. | ▲ Buy | Grant | 336,965 | $3.4M | 7/20/2026 |
| Harlan Waksal | ▼ Sell | Other | 30,000 | — | 7/20/2026 |
| Adam Leo Stone | ▲ Buy | Grant | 286,250 | $2.9M | 6/13/2024 |
| Michael Seth Altman | ▲ Buy | Grant | 286,250 | $2.9M | 6/13/2024 |
| Perceptive Capital Solutions Holdings | ▼ Sell | Other | 286,250 | $2.9M | 6/13/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Freenome highlights CRC screening market potential
Freenome is emphasizing the large addressable market for its colorectal cancer screening test, noting it can reach 50 million patients while facing less direct competition. This narrative aims to support the company's growth outlook as the stock trades near its 52-week high range.
Freenome highlights CRC screening market potential. Freenome is emphasizing the large addressable market for its colorectal cancer screening test, noting it can reach 50 million patients while facing less direct competition. This narrative aims to support the company's growth outlook as the stock trades near its 52-week high range.